Steven Cohen Cure Vac N.V. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cure Vac N.V. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 780,005 shares of CVAC stock, worth $2.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
780,005
Previous 2,422,728
67.8%
Holding current value
$2.33 Million
Previous $8.24 Million
72.16%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CVAC
# of Institutions
93Shares Held
12.3MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$7.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$6.74 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$4.69 Million10.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$3.02 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL400KShares$1.2 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $561M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...